M Opravil
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study
Young J, Bucher H, Battegay M, Hirschel B, Vernazza P, Bernasconi E, Cavassini M, Fux C, Rickenbach M, Böni J, Yerly S, Opravil M, Günthard H, Scherrer A, for the Swiss HIV Cohort Study. Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study. HIV Med 2010
18.10.2010Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study
18.10.2010HIV Med 2010
Young J, Bucher Hc, Battegay M, Hirschel B, Vernazza Pietro, Bernasconi E, Cavassini M, Fux Ca, Rickenbach M, Böni J, Yerly S, Opravil M, Günthard Hf, Scherrer Au, for the Swiss HIV Cohort Study
Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006
Nguyen A, Hirschel B, Perneger T, Schmid P, Tarr P, Evison J, Opravil M, Battegay M, Bernasconi E, Schiffer V, Calmy A, Swiss HIV Cohort Study. Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006. HIV medicine 2008; 9:142-50.
01.03.2008Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006
01.03.2008HIV medicine 2008; 9:142-50
Nguyen A, Hirschel B, Perneger T, Schmid Patrick, Tarr P E, Evison J-M, Opravil M, Battegay M, Bernasconi E, Schiffer V, Calmy A, Swiss HIV Cohort Study
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy
Bertschy S, Furrer H, Christen A, Chave J, Flepp M, Schmid P, Schiffer V, Bernasconi E, Cavassini M, Opravil M, Swiss HIV Cohort Study. Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006; 12:666-71.
01.07.2006Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy
01.07.2006Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006; 12:666-71
Bertschy S, Furrer H, Christen A, Chave J-P, Flepp M, Schmid Patrick, Schiffer V, Bernasconi E, Cavassini M, Opravil M, Swiss HIV Cohort Study
Predictive value of adherence in patients starting highly active antiretroviral treatment for HIV infection
Wagels T, Amiet R, Battegay M, Guex A, Opravil M, Vernazza P, Swiss HIV Cohort Study Group. Predictive value of adherence in patients starting highly active antiretroviral treatment for HIV infection. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2004; 134:678-80.
13.11.2004Predictive value of adherence in patients starting highly active antiretroviral treatment for HIV infection
13.11.2004Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2004; 134:678-80
Wagels T, Amiet R, Battegay M, Guex A C, Opravil M, Vernazza Pietro, Swiss HIV Cohort Study Group
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study
Boubaker K, Francioli P, Rickenbach M, Opravil M, Egger M, Bernasconi E, Chave J, Boggian K, Hirschel B, Haensel A, Furrer H, Sudre P, Flepp M, Telenti A. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis 2001; 33:1931-7.
23.10.2001Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study
23.10.2001Clin Infect Dis 2001; 33:1931-7
Boubaker K, Francioli P, Rickenbach M, Opravil M, Egger M, Bernasconi E, Chave J P, Boggian Katia, Hirschel B, Haensel A, Furrer H, Sudre P, Flepp M, Telenti A
Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection
Bisset L, Opravil M, Grob P, Weber R, Dubs R, Vernazza P, Battegay M, Fischer M, Cone R, Swiss HIV Cohort Study. Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection. Journal of acquired immune deficiency syndromes (1999) 2001; 27:266-71.
01.07.2001Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection
01.07.2001Journal of acquired immune deficiency syndromes (1999) 2001; 27:266-71
Bisset L R, Opravil M, Grob P J, Weber R, Dubs R W, Vernazza Pietro, Battegay M, Fischer M, Cone R W, Swiss HIV Cohort Study
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study
Furrer H, Egger M, Flepp M, Rickenbach M, Boggian K, Schiffer V, Bucher H, Telenti A, Bernasconi E, Rossi M, Opravil M, Swiss HIV Cohort Study. Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study. AIDS 2001; 15:501-7.
09.03.2001Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study
09.03.2001AIDS 2001; 15:501-7
Furrer H, Egger M, Flepp M, Rickenbach M, Boggian Katia, Schiffer V, Bucher H, Telenti A, Bernasconi E, Rossi M, Opravil M, Swiss HIV Cohort Study
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study
Rutschmann O, Perrin L, Leduc D, Fagard C, Bernasconi E, Malinverni R, Telenti A, Ledergerber B, Opravil M, Bucher H, Vernazza P, Hirschel B. Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study. AIDS (London, England) 2000; 14:2145-51.
29.09.2000Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study
29.09.2000AIDS (London, England) 2000; 14:2145-51
Rutschmann O T, Perrin L, Leduc D, Fagard C, Bernasconi E, Malinverni R, Telenti A, Ledergerber B, Opravil M, Bucher H C, Vernazza Pietro, Hirschel B
Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort Study
Opravil M, Lüthy R, Roos M, Knuchel M, Huber W, Ott P, Bisset L, Lorenzi P, Bassetti S, Vernazza P, Fischer M, Cone R, Weber R. Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2000; 23:17-25.
01.01.2000Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort Study
01.01.2000Journal of acquired immune deficiency syndromes (1999) 2000; 23:17-25
Opravil M, Lüthy R, Roos M, Knuchel M C, Huber W, Ott P, Bisset L R, Lorenzi P, Bassetti S, Vernazza Pietro, Fischer M, Cone R W, Weber R
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study
Ledergerber B, Francioli P, Sudre P, Kaufmann D, Opravil M, Bernasconi E, Vernazza P, Battegay M, Furrer H, Hirschel B, Weber R, Erard V, Egger M, Telenti A. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA : the journal of the American Medical Association 1999; 282:2220-6.
15.12.1999AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study
15.12.1999JAMA : the journal of the American Medical Association 1999; 282:2220-6
Ledergerber B, Francioli P, Sudre P, Kaufmann D, Opravil M, Bernasconi E, Vernazza Pietro, Battegay M, Furrer H, Hirschel B, Weber R, Erard V, Egger M, Telenti A
Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study
Zinkernagel C, Ledergerber B, Battegay M, Cone R, Vernazza P, Hirschel B, Opravil M. Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study. AIDS (London, England) 1999; 13:1587-9.
20.08.1999Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study
20.08.1999AIDS (London, England) 1999; 13:1587-9
Zinkernagel C, Ledergerber B, Battegay M, Cone R W, Vernazza Pietro, Hirschel B, Opravil M
Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study
Weber R, Meyenberger C, Opravil M, Kaiser L, Briner J, Spycher M, Pfyffer G, Altwegg M, Zbinden R, Ledergerber B, Flepp M. Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study. Archives of internal medicine 1999; 159:1473-80.
12.07.1999Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study
12.07.1999Archives of internal medicine 1999; 159:1473-80
Weber R, Meyenberger Christa, Opravil M, Kaiser L, Briner J, Spycher M A, Pfyffer G E, Altwegg M, Zbinden R, Ledergerber B, Flepp M
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study
Furrer H, Flepp M, Rickenbach M, Vernazza P, Telenti A, Battegay M, Hirschel B, Bernasconi E, Opravil M, Egger M, Malinverni R. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. The New England journal of medicine 1999; 340:1301-6.
29.04.1999Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study
29.04.1999The New England journal of medicine 1999; 340:1301-6
Furrer H, Flepp M, Rickenbach M, Vernazza Pietro, Telenti A, Battegay M, Hirschel B, Bernasconi E, Opravil M, Egger M, Malinverni R
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study
Ledergerber B, Francioli P, Furrer H, Flepp M, Sudre P, Vernazza P, Battegay M, Hirschel B, Telenti A, Opravil M, Egger M, Weber R. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet 1999; 353:863-8.
13.03.1999Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study
13.03.1999Lancet 1999; 353:863-8
Ledergerber B, Francioli P, Furrer H, Flepp M, Sudre P, Vernazza Pietro, Battegay M, Hirschel B, Telenti A, Opravil M, Egger M, Weber R
Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study
Bisset L, Cone R, Huber W, Battegay M, Vernazza P, Weber R, Grob P, Opravil M. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study. AIDS (London, England) 1998; 12:2115-23.
12.11.1998Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study
12.11.1998AIDS (London, England) 1998; 12:2115-23
Bisset L R, Cone R W, Huber W, Battegay M, Vernazza Pietro, Weber R, Grob P J, Opravil M
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study
Rutschmann O, Perrin L, Yerly S, Leduc D, Sudre P, Bernasconi E, Bucher H, Vernazza P, Malinverni R, Iten A, Opravil M, Hirschel B. A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study. AIDS (London, England) 1998; 12:F71-7.
28.05.1998A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study
28.05.1998AIDS (London, England) 1998; 12:F71-7
Rutschmann O T, Perrin L H, Yerly S, Leduc D, Sudre P, Bernasconi E, Bucher H C, Vernazza Pietro, Malinverni R, Iten A, Opravil M, Hirschel B
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study
Rutschmann O, Yerly S, Perrin L, Bernasconi E, Bucher H, Vernazza P, Malinverni R, Iten A, Opravil M, Hirschel B. Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study. Antiviral therapy 1998; 3 Suppl 4:65-7.
01.01.1998Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study
01.01.1998Antiviral therapy 1998; 3 Suppl 4:65-7
Rutschmann O T, Yerly S, Perrin L H, Bernasconi E, Bucher H, Vernazza Pietro, Malinverni R, Iten A, Opravil M, Hirschel B